Live from the NIH registry
Studies recruiting near Huntington Beach right now
Top 25 of 2,841 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (28.3 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (2.9 mi)
· Sponsor: Takeda
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Associates of Southern California — Huntington Beach, California (2.5 mi)
· Sponsor: Genentech, Inc.
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Santa Ana, California (8.4 mi)
· Sponsor: Axsome Therapeutics, Inc.
Effect of Electro-Acupuncture on Blood Pressure
Hypertension
N/A
Interventional 160 participants sought
Susan Samueli Integrative Health Institute — Irvine, California (10.4 mi)
· Sponsor: University of California, Irvine
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Southern California — Los Angeles, California (28.3 mi)
· Sponsor: AB Science
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Glaucoma, Ocular Surface Disease
N/A
Observational 75 participants sought
Doheny Eye Center UCLA — Fountain Valley, California (2.9 mi)
· Sponsor: University of California, Los Angeles
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Colorectal Cancer Metastatic
Phase 2
Interventional 20 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (6.8 mi)
· Sponsor: Buzzard Pharmaceuticals
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2
Interventional 21 participants sought
UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California (28.3 mi)
· Sponsor: Jonsson Comprehensive Cancer Center
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
ATP Clinical Research Inc. — Irvine, California (10.4 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Food is Medicine Prospective Study
Wounds and Injuries
N/A
Observational 75 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (28.3 mi)
· Sponsor: Cedars-Sinai Medical Center
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Los Angeles, California (28.3 mi)
· Sponsor: Avenzo Therapeutics, Inc.
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Providence Medical Foundation ( Site 0141) — Fullerton, California (12.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
University of California Irvine — Orange, California (10.6 mi)
· Sponsor: Nurix Therapeutics, Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California (10.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
University of Southern California — Los Angeles, California (28.3 mi)
· Sponsor: Cook Research Incorporated
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
Glioblastoma, Recurrent Glioblastoma
N/A
Interventional 50 participants sought
UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California (28.3 mi)
· Sponsor: Jonsson Comprehensive Cancer Center
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Advanced Medical Research — La Palma, California (10.7 mi)
· Sponsor: Novartis Pharmaceuticals
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center — Torrance, California (21.7 mi)
· Sponsor: Synairgen Research Ltd.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Medvin Clinical Research - Covina — Covina, California (28.0 mi)
· Sponsor: Crystalys Therapeutics
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
University of California Irvine Medical Center — Orange, California (10.6 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Urothelial Carcinoma, Muscle-invasive Bladder Cancer
Phase 2
Interventional 23 participants sought
Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California (10.6 mi)
· Sponsor: University of California, Irvine
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
Cedars Sinai Medical Center - 127 San Vicente Blvd — Los Angeles, California (28.3 mi)
· Sponsor: Takeda
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Phase 2, Phase 3
Interventional 740 participants sought
Corxel Investigational Site — Long Beach, California (11.8 mi)
· Sponsor: Corxel Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
SDS Clinical Trials, Inc-California-Santa Ana — Santa Ana, California (8.4 mi)
· Sponsor: Eisai Inc.